• 1
    Wake, D. J., Walker, BR. (2004) 11 Beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome. Mol Cell Endocrinol. 215: 4554.
  • 2
    Masuzaki, H., Paterson, J., Shinyama, H., et al (2001) A transgenic model of visceral obesity and the metabolic syndrome. Science 294: 21662170.
  • 3
    Boullu-Ciocca, S., Dutour, A., Guillaume, V., Achard, V., Oliver, C., Grino, M. (2005) Postnatal diet-induced obesity in rats upregulates systemic and adipose tissue glucocorticoid metabolism during development and in adulthood: its relationship with the metabolic syndrome. Diabetes 54: 197203.
  • 4
    Paulmyer-Lacroix, O., Boullu, S., Oliver, C., Alessi, M-C, Grino, M. (2002) Expression of the mRNA coding for 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue of obese patients: an. J Clin Endocrinol Metab. 87: 27012705.
  • 5
    Rask, E., Walker, B. R., Soderberg, S., et al (2002) Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11β-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab. 87: 33303336.
  • 6
    Lindsay, R. S., Wake, D. J., Nair, S., et al (2003) Subcutaneous adipose 11β-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. J Clin Endocrinol Metab. 88: 27382744.
  • 7
    Tomlinson, J. W., Sinha, B., Bujalska, I., Hewison, M., Stewart, PM. (2002) Expression of 11 beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity. J Clin Endocrinol Metab. 87: 56305635.
  • 8
    Hewitt, K. N., Walker, E. A., Stewart, PM. (2005) Minireview: hexose-6-phosphate dehydrogenase and redox control of 11β-hydroxysteroid dehydrogenase type 1 activity. Endocrinology 146: 25392543.
  • 9
    Lihn, A. S., Bruun, J. M., He, G., Pedersen, S. B., Jensen, P. F., Richelsen, B. (2004) Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol. 219: 915.
  • 10
    Andrew, R., Westerbacka, J., Wahren, J., Yki-Järvinen, H., Walker, BR. (2005) The contribution of visceral adipose tissue to splanchnic cortisol production in healthy humans. Diabetes 54: 13641370.
  • 11
    Sandeep, T. C., Andrew, R., Homer, N. Z. M., Andrews, R. C., Smith, K., Walker, BR. (2005) Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone. Diabetes 54: 872879.
  • 12
    Basu, R., Singh, R. J., Basu, A., et al (2005) Obesity and type 2 diabetes do not alter splanchnic cortisol production in humans. J Clin Endocrinol Metab. 90: 39193926.
  • 13
    Engeli, S., Bohnke, J., Feldpausch, M., et al (2004) Regulation of 11β-HSD genes in human adipose tissue: influence of central obesity and weight loss. Obes Res. 12: 917.
  • 14
    Dallman, M. F., Pecoraro, N., Akana, S. F., et al (2003) 2003 Chronic stress and obesity: a new view of “comfort food”. Proc Natl Acad Sci U S A 100: 1169611701.
  • 15
    Rebuffe-Scrive, M., Bronnegard, M., Nilsson, A., Eldh, J., Gustafsson, J. A., Björntorp, P. (1990) Steroid hormone receptors in human adipose tissues. J Clin Endocrinol Metab. 71: 12151219.
  • 16
    Hermanowski-Vosatka, A., Balkovec, J. M., Cheng, K., et al (2005) 11β-HSD-1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice. J Exp Med. 202: 517527.